The Evidence and the Hunch
There is a particular kind of conversation that only happens when two people genuinely respect each other and genuinely disagree. Not the performative disagreement of cable news, not the polite nodding of people who don't want to ruin the vibe — but the real thing, where both parties leave slightly rattled and slightly enlarged. That's what Eric Topol and Dax Shepard do here, and it's a rarer thing than either of them probably realizes.
Dax comes in armed with his own body as evidence. He smoked crack. He smoked cigarettes for twenty years. He has psoriatic arthritis that he managed not through the pharmaceutical conveyor belt but through the painstaking elimination of garlic and gluten and peanuts, one humiliating dietary restriction at a time. He got a full-body MRI and found out he had scoliosis. He eats a quantity of red meat that, by his own admission, would break Eric Topol's heart. He is, in other words, a man who has conducted an n-of-one experiment on himself for five decades and arrived at strong opinions. And he is not wrong to have them.
Topol is something rarer in the longevity space: an optimist with receipts. He watched Merck suppress evidence that Vioxx was killing people. He watched the Sacklers buy their way out of consequences for the opioid crisis. He has seen, from the inside, how the wall between research and pharmaceutical money is not a wall at all but a suggestion, permeable at best, sometimes not even that. And yet he shows up here not bitter but blazing — talking about B cells that reboot like a computer after a control-alt-delete, about old mice made young again through partial epigenetic reprogramming, about organ clocks that can tell you your liver is sixty-five while your heart is thirty-eight. He is a man who has stared into the machinery of institutional corruption and come out the other side somehow more in love with science.
The tension between them on peptides is the episode's beating heart. Dax makes the GLP-1 argument — these things were off-label once too, and now they're transforming obesity medicine, addiction treatment, maybe Alzheimer's prevention. Topol concedes the jewels might be hidden in there somewhere but wants the data first, wants the journals, wants the rigor. Neither of them is wrong. What they're really arguing about is the acceptable level of uncertainty when your body is the laboratory and time is the variable you're trying to extend.
Meanwhile, Monica bursts in from a bike ride, verging on tears from pride, and the whole apparatus of longevity science pauses for the thing it's actually in service of: a person, out of breath, so happy she has to share it with someone. That's the point Eric Topol has been making for two hundred pages without quite saying it. Health span isn't about the years. It's about having enough of them left to go on a bike ride and then need to tell somebody.